Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing

New upgrade:   Journal your trades with more detail

Read How
Market News Market Pulse Stocks News ETF News Crypto News

Journey Medical Corporation

Contributing Author

Recent Articles by Journey Medical Corporation

Aug-12
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights FBIO +5.36% FBIO +8.36% DERM GlobeNewswire
Aug-05
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 FBIO DERM GlobeNewswire
May-19
Journey Medical Corporation to Participate in A.G.P.'s Annual Virtual Healthcare Conference FBIO DERM GlobeNewswire
May-13
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights DERM DERM +22.35% FBIO GlobeNewswire
May-06
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 FBIO FBIO -5.88% DERM GlobeNewswire
Apr-21
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi DERM -5.20% FBIO GlobeNewswire
Mar-25
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights DERM DERM -30.01% FBIO GlobeNewswire
Mar-18
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026 DERM -5.07% FBIO GlobeNewswire
Dec-10
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology DERM -5.29% FBIO GlobeNewswire
Nov-12
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights DERM DERM -15.31% FBIO GlobeNewswire
Nov-05
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 DERM FBIO GlobeNewswire
Oct-24
Journey Medical Corporation Reports Combined Emrosi (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference DERM FBIO GlobeNewswire
Oct-08
Journey Medical Corporation to Participate in October 2025 Investor Conferences FBIO DERM GlobeNewswire
Sep-03
Journey Medical Corporation to Participate in September 2025 Investor Conferences DERM FBIO GlobeNewswire
Aug-18
Journey Medical Corporation to Present at the Emerging Growth Conference FBIO +6.13% DERM GlobeNewswire
Aug-12
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights DERM +8.51% DERM -15.11% FBIO GlobeNewswire
Aug-07
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 FBIO DERM GlobeNewswire
Aug-05
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 FBIO DERM GlobeNewswire
Jul-14
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi FBIO DERM GlobeNewswire
Jun-24
Journey Medical to Join Russell 2000 and Russell 3000 Indexes DERM +8.93% FBIO GlobeNewswire
Jun-20
Journey Medical Corporation Announces Emrosi Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference DERM FBIO GlobeNewswire
Jun-09
Journey Medical Corporation Announces Emrosi Featured on "The Balancing Act" Airing on Lifetime TV FBIO +6.50% DERM GlobeNewswire
May-14
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights DERM -5.54% DERM +18.93% FBIO FBIO +7.23% GlobeNewswire
May-07
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 DERM +6.92% FBIO GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)